WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 4'0901 Infant (under 12 months) mortality rate: 132
GDP / capita (US$): 9'4431 Child (under 5 years) mortality rate: 142

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 3'162  3'154  3'150  3'151  3'157  3'305  3'447  2'735 
Births 40  40  40  40  41  62  85  80 
Surviving infants 40  39  39  39  40  61  82  77 
Pop. less than 5 years 198  198  197  197  197  321  415  375 
Pop. less than 15 years 675  696  719  743  766  1'003  1'173  1'044 
Female 15-49 years 811  807  805  809  815  866  864  640 

Number of reported case

(Click for retrospective incidence data for Albania)
Diphtheria 17 
Japanese encephalitis
Measles 10  662 
Mumps 18  21  22  50  1'651 
Pertussis 16  10  10  89  329  137 
Polio*
Rubella 1'752 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 15 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Albania)
Vaccine year result method % card seen                                                
BCG 2008  98  DHS   95.8  96  100  97  100  93  94 
DTP1 2008  100  DHS   95.8  99  99  99  99  98 
DTP3 2008  98  DHS   95.8  99  99  98  99  97  94 
HepB_BD          97  100  98  98  98 
HepB3 2008  98  DHS   95.8  99  99  98  99  96 
Hib3          99  99  98 
JapEnc         
MCV 2008  97  DHS   95.8  98  99  97  98  95 
MCV2          99  99  98  98 
PCV1          99 
PCV3          99 
Pol3 2008  98  DHS   95.8  99  99  98  99  97 
Rota1         
Rota_last         
Rubella1          98  99  97  98 
TT2plus          85  80  83  89 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Albania)
BCG 99  99  99  97  99  93  94  93 
DTP1 99  99  99  99  99  98  97  97 
DTP3 99  99  99  98  99  97  94  94 
HepB3 99  99  99  98  99  96 
Hib3 99  99  99  98 
MCV 99  99  99  97  98  95  88  90 
PAB 87  87  87  87  87  86  30 
PCV3
Pol3 99  99  99  98  99  97  89  92 
Rota_last

Number of districts in the country 36  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 6 years; Yes
DTwP 2 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HepB birth; Yes
MMR 1, 5 years; Yes
OPV 2, 4, 6 months; 2, 6 years; Yes
Pneumo_conj 2, 4, 6 months;
Td 14 years; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes    Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2009-2013    2009 -2013  2009 -2013  2009 -2013  2002-2007  2002-2007 
Nº of districts with microplans that include activities to raise immunization coverage number   36  2'003   

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes    Yes         

System performance

Total number of districts in country number 36    36  36  36  36  36 
Nº districts with DTP3 coverage >=80% number 36    36  36  36  36  36 
% of districts with DTP3 coverage >=80% From 0 to 100% 100    100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 35    36  28  34     
% of districts with MCV1 coverage >=95% From 0 to 100% 97    100  78  94     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes    Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes    Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100    100  100  100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.